Angiogenesis and lymphangiogenesis of skin cancers

Hematology/Oncology Clinics of North America

Volumn 18, Issue 5, 2004, Pages 1059-1070

  Dadras, Soheil S ^a   Detmar, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; HUMAN; LYMPHANGIOGENESIS; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVIEW; SKIN CANCER;

HUMANS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MELANOMA; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS;

EID: 5044223787     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2004.06.009     Document Type: Review

References (56)

1. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 1999 CA Cancer J Clin 49 1 1999 8 31
2. M.A. Weinstock Early detection of melanoma JAMA 284 7 2000 886 889
3. A. Breslow Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 5 1970 902 908
4. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, and D.G. Coit Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 16 2001 3635 3648
5. J. Guitart, L. Lowe, M. Piepkorn, V.G. Prieto, M.S. Rabkin, and S.G. Ronan Histological characteristics of metastasizing thin melanomas: a case- control study of 43 cases Arch Dermatol 138 5 2002 603 608
6. M.F. Kalady, R.R. White, J.L. Johnson, D.S. Tyler, and H.F. Seigler Thin melanomas: predictive lethal characteristics from a 30-year clinical experience Ann Surgt 238 4 2003 528 535
7. M.H. Schmid-Wendtner, J. Baumert, J. Eberle, G. Plewig, M. Volkenandt, and C.A. Sander Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977â€"98 Br J Dermatol 149 4 2003 788 793
8. N.W. Gale, and G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev 13 9 1999 1055 1066
9. G. Oliver, and M. Detmar The rediscovery of the lymphatic system. Old and new insights into the development and biological function of lymphatic vascular system Genes Dev 16 2002 773 783
10. K. Alitalo, and P. Carmeliet Molecular mechanisms of lymphangiogenesis in health and disease Cancer Cell 1 3 2002 219 227
11. M. Detmar, and S. Hirakawa The formation of lymphatic vessels and its importance in the setting of malignancy J Exp Med 6 2002 713 718
12. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasisâ€"correlation in invasive breast carcinoma N Engl J Med 324 1 1991 1 8
13. B.A. Warren, and P. Shubik The growth of the blood supply to melanoma transplants in the hamster cheek pouch Lab Invest 15 2 1966 464 478
14. R.L. Barnhill, K. Fandrey, M.A. Levy, M.C. Mihm Jr, and B. Hyman Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma Lab Invest 67 3 1992 331 337
15. M.C. Mihm Jr, W.H. Clark Jr, and R.J. Reed The clinical diagnosis of malignant melanoma Semin Oncol 2 2 1975 105 118
16. W.R. Hubler Jr, and J.E. Wolf Jr Melanoma. Tumor angiogenesis and human neoplasia Cancer 38 1 1976 187 192
17. A. Srivastava, P. Laidler, L.E. Hughes, J. Woodcock, and E.J. Shedden Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study Eur J Cancer Clin Oncol 22 10 1986 1205 1209
18. M. Streit, and M. Detmar Angiogenesis, lymphangiogenesis and melanoma metastasis Oncogene 22 2003 3172 3179
19. R.L. Barnhill, and M.A. Levy Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis Am J Pathol 143 1 1993 99 104
20. J. Marcoval, A. Moreno, J. Graells, A. Vidal, J.M. Escriba, and R.M. Garcia Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase J Cutan Pathol 24 4 1997 212 218
21. H. Erhard, F.J. Rietveld, M.C. van Altena, E.B. Brocker, D.J. Ruiter, and R.M. de Waal Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis Melanoma Res 7 Suppl 2 1997 S19 S26
22. A. Srivastava, P. Laidler, R.P. Davies, K. Horgan, and L.E. Hughes The prognostic significance of tumor vascularity in intermediate- thickness (0.76â€"4.0 mm thick) skin melanoma. A quantitative histologic study Am J Pathol 133 2 1988 419 423
23. C.H. Graham, J. Rivers, R.S. Kerbel, K.S. Stankiewicz, and W.L. White Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas Am J Pathol 145 3 1994 510 514
24. O. Straume, H.B. Salvesen, and L.A. Akslen Angiogenesis is prognostically important in vertical growth phase melanomas Int J Oncol 15 3 1999 595 599
25. T. Vlaykova, P. Laurila, T. Muhonen, M. Hahka-Kemppinen, A. Jekunen, and K. Alitalo Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression Melanoma Res 9 1 1999 59 68
26. M. Kashani-Sabet, R.W. Sagebiel, C.M.M. Ferreira, M. Nosrati, and J.R. Miller Tumor vascularity in the prognostic assessment of primary cutaneous melanoma J Clin Oncol 20 2002 1826 1831
27. P. Carnochan, J.C. Briggs, G. Westbury, and A.J. Davies The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85â€"1.25 mm in thickness Br J Cancer 64 1 1991 102 107
28. K.J. Busam, M. Berwick, K. Blessing, K. Fandrey, S. Kang, and T. Karaoli Tumor vascularity is not a prognostic factor for malignant melanoma of the skin Am J Pathol 147 4 1995 1049 1056
29. S.S. Dadras, T. Paul, J. Bertoncini, L.F. Brown, A. Muzikansky, and D.G. Jackson Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival Am J Pathol 162 6 2003 1951 1960
30. S. Ilmonen, A.L. Kariniemi, T. Vlaykova, T. Muhonen, S. Pyrhonen, and S. Asko-Seljavaara Prognostic value of tumour vascularity in primary melanoma Melanoma Res 9 3 1999 273 278
31. W. Weninger, A. Uthman, J. Pammer, A. Pichler, C. Ballaun, and I.M. Lang Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors Lab Invest 75 5 1996 647 657
32. T. Hawighorst, P. Velasco, M. Streit, T.R. Kyriakides, L.F. Brown, and P. Bornstein Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism EMBO J 20 2001 2631 2640
33. T. Hawighorst, H. Oura, M. Streit, L. Janes, L. Nguyen, and L.F. Brown Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice Oncogene 21 2002 7945 7956
34. J.E. Gershenwald, W. Thompson, P.F. Mansfield, J.E. Lee, M.I. Colome, and C.H. Tseng Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 3 1999 976 983
35. S.A. Stacker, M.E. Baldwin, and M.G. Achen The role of tumor lymphangiogenesis in metastatic spread FASEB J 16 9 2002 922 934
36. M. Papoutsi, G. Siemeister, K. Weindel, S.I. Tomarev, H. Kurz, and C. Schachtele Active interaction of human A375 melanoma cells with the lymphatics in vivo Histochem Cell Biol 114 5 2000 373 385
37. P. Salven, A. Lymboussaki, P. Heikkila, S.H. Jaaskela, B. Enholm, and K. Aase Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors Am J Pathol 153 1 1998 103 108
38. M.G. Achen, R.A. Williams, M.P. Minekus, G.E. Thornton, K. Stenvers, and P.A. Rogers Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis J Pathol 193 2 2001 147 154
39. R. Prevo, S. Banerji, D.J. Ferguson, S. Clasper, and D.G. Jackson Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium J Biol Chem 276 22 2001 19420 19430
40. J.T. Wigle, N. Harvey, M. Detmar, I. Lagutina, G. Grosveld, and M.D. Gunn An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype EMBO J 21 2002 1505 1513
41. J. Valencak, E. Heere-Ress, T. Kopp, S.F. Schoppmann, H. Kittler, and H. Pehamberger Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma Eur J Cancer 40 3 2004 358 364
42. J.D. Shields, M. Borsetti, H. Rigby, S.J. Harper, P.S. Mortimer, and J.R. Levick Lymphatic density and metastatic spread in human malignant melanoma Br J Cancer 90 3 2004 693 700
43. N.J. Beasley, R. Prevo, S. Banerji, R.D. Leek, J. Moore, and P. van Trappen Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer Cancer Res 62 5 2002 1315 1320
44. M. Skobe, T. Hawighorst, D.G. Jackson, R. Prevo, L. Janes, and P. Velasco Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Nat Med 7 2 2001 192 198
45. M. Skobe, L.M. Hamberg, T. Hawighorst, M. Schirner, K. Alitalo, and M. Detmar Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma Am J Pathol 159 3 2001 893 903
46. S.A. Stacker, C. Caesar, M.E. Baldwin, G.E. Thornton, R.A. Williams, and R. Prevo VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat Med 7 2 2001 186 191
47. S.J. Mandriota, L. Jussila, M. Jeltsch, A. Compagni, D. Baetens, and R. Prevo Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis EMBO J 20 2001 672 682
48. T. Karpanen, M. Egeblad, M.J. Karkkainen, H. Kubo, S. Yla-Herttuala, and M. Jaattela Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth Cancer Res 61 5 2001 1786 1790
49. Y. He, K. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-Herttuala, and T. Takahashi Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling J Natl Cancer Inst 94 11 2002 819 825
50. S.M. Maula, M. Luukkaa, R. Grenman, D. Jackson, S. Jalkanen, and R. Ristamaki Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region Cancer Res 63 8 2003 1920 1926
51. O. Straume, D.G. Jackson, and L.A. Akslen Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma Clin Cancer Res 9 1 2003 250 256
52. R.K. Jain, and P.F. Carmeliet Vessels of death or life Sci Am 285 6 2001 38 45
53. H. Saeki, A.M. Moore, M.J. Brown, and S.T. Hwang Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes J Immunol 162 5 1999 2472 2475
54. M.D. Gunn, K. Tangemann, C. Tam, J.G. Cyster, S.D. Rosen, and L.T. Williams A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes Proc Natl Acad Sci U S A 95 1 1998 258 263
55. A. Muller, B. Homey, H. Soto, N. Ge, D. Cattron, and M.E. Buchanan Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
56. H.E. Wiley, E.B. Gonzalez, W. Maki, M.M. Wu, and S.T. Hwang Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma J Natl Cancer Inst 93 21 2001 1638 1643